Canada Pension Plan Investment Board
DAWN

Canada Pension Plan Investment Board’s Day One Biopharmaceuticals DAWN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,100
Closed -$602K – 1743
2026
Q1 		$602K Sell
28,100
-10,400
-27% -$147K ﹤0.01% 1172
2025
Q4 		$359K Buy
+38,500
New +$322K ﹤0.01% 1438

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Pension Plan Investment Board's DAWN Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 28,100 shares — an estimated $602K sold.

Canada Pension Plan Investment Board first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $602K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 28,100 Day One Biopharmaceuticals shares in Q2 2026, an estimated $602K.
  • Canada Pension Plan Investment Board first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Day One Biopharmaceuticals position peaked at $602K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.